Sign in to fuzzto save your conversations, follow your research and come back anytime.
Shukra Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Sales | 10.58 | 13.27 | 5.39 | 5.88 | 39.13 | 6.32 | 23.52 |
| Expenses | 6.65 | 5.95 | 4.07 | 6.3 | 12 | 5.62 | 4.38 |
| EBITDA | 3.93 | 7.32 | 1.32 | -0.42 | 27.13 | 0.7 | 19.14 |
| Depreciation | 0.7 | 0.94 | 0.79 | 0.81 | 0.84 | 1.01 | 1.08 |
| EBIT | 3.23 | 6.38 | 0.53 | -1.23 | 26.29 | -0.31 | 18.06 |
| Interest | 0.15 | 0.27 | 0.27 | 0.29 | 0.28 | 0.26 | 0.43 |
| Profit Before Tax | 3.08 | 6.11 | 0.26 | -1.52 | 26.01 | -0.57 | 17.63 |
| Net Profit | 3.16 | 5.39 | 1.03 | 2.38 | 20.36 | -1.72 | 12.96 |
| EPS | 0.72 | 0.12 | 0.02 | 0.05 | 0.47 | -0.04 | 0.3 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Operating Cash Flow | 7.92 | 3.15 |
| Investing Cash Flow | -1.26 | -14.18 |
| Financing Cash Flow | -4.52 | 4.83 |
| Net Cash Flow | 2.14 | -6.2 |
| Metric (₹ crore) | FY25 | FY26 |
|---|---|---|
| Equity / Shareholders' Funds | 62.84 | 89.83 |
| Total Liabilities | 23.94 | 27.58 |
| Total Assets | 86.77 | 117.41 |